Oxford Science Enterprises
Track Record
34 Deals
Total Volume
£658,103,514
Deal Activity Timeline
Recent Transactions
VC Funding
Sept 2026 MCatalysis
£3,685,977
VC Funding
Jul 2026 Vivid Dx
£11,287,566
VC Funding
Jul 2025 Ultromics
£41,559,933
Lead: GV
Lead: Allegis Capital
Lead: L&G Capital
Lead: Blue Venture Fund
Lead: UPMC Enterprises
Lead: Oxford University
Lead: Lightrock
VC Funding
Mar 2025 Mixergy
£12,000,000
VC Funding
Sept 2024 FluoRok
£7,700,000
VC Funding
Jul 2024 Fractile
£11,654,420
Lead: NATO Innovation Fund
Lead: Amar Shah
Lead: Kindred Capital
Lead: Inovia Capital
Lead: Stan Boland
Lead: Hermann Hauser
Lead: Cocoa VC
VC Funding
Jul 2024 Natcap
£7,788,996
Lead: David Craig
Lead: Alea Iacta Est
Lead: Pelican Capital
Lead: Norinchukin Capital
Lead: Yeo Ventures
Lead: MW&L Capital Partners
Lead: André Hoffmann
VC Funding
Jun 2024 PQShield
£29,172,320
VC Funding
May 2024 Grey Wolf Therapeutics
£36,097,752
Lead: Pfizer Ventures
Lead: Andera Partners
Lead: ICG’s Life Sciences
Lead: British Patient Capital
Lead: Canaan
VC Funding
Sept 2023 Navenio
£5,093,805
VC Funding
Jan 2023 Grey Wolf Therapeutics
£39,553,052
VC Funding
Jan 2023 Oxford Ionics
£30,000,000
VC Funding
Nov 2022 Osler Diagnostics
£74,301,021
VC Funding
Nov 2022 Util
£5,316,734
VC Funding
Oct 2022 Nucleome Therapeutics
£33,363,034
VC Funding
Jul 2022 Brill Power
£8,806,966
VC Funding
Jul 2022 Oxford Quantum Circuits
£38,709,505
Lead: Lansdowne Partners
Lead: British Patient Capital
VC Funding
Jun 2022 ORCA Computing
£11,959,369
VC Funding
Jun 2022 moa Technology Limited
£34,979,014
Lead: Bits x Bites Growth Fund
Lead: University of Oxford
Lead: BGF Investments
Lead: IP Group
Lead: Lansdowne Partners
Lead: Parkwalk Advisors
VC Funding
Apr 2022 OMass Therapeutics
£75,500,000
VC Funding
Feb 2022 First Light Fusion
£33,292,683
